Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review

  • ID: 4415771
  • SWOT Analysis
  • 56 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Albireo Pharma Inc
  • Depomed Inc
  • DURECT Corp
  • Elite Pharmaceuticals Inc
  • MORE
Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analysts summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells its products in the US, France, and Ireland. The company operates in St. Louis, Missouri, and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Aug 07, 2018: Avadel Pharmaceuticals reports second quarter 2018 financial results
May 02, 2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results
Mar 22, 2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer
Mar 08, 2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results
Dec 29, 2017: Avadel Pharmaceuticals Issues 2018 Corporate Outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Albireo Pharma Inc
  • Depomed Inc
  • DURECT Corp
  • Elite Pharmaceuticals Inc
  • MORE
Section 1 - About the Company
  • Avadel Pharmaceuticals Plc - Key Facts
  • Avadel Pharmaceuticals Plc - Key Employees
  • Avadel Pharmaceuticals Plc - Key Employee Biographies
  • Avadel Pharmaceuticals Plc - Major Products and Services
  • Avadel Pharmaceuticals Plc - History
  • Avadel Pharmaceuticals Plc - Company Statement
  • Avadel Pharmaceuticals Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Avadel Pharmaceuticals Plc - Business Description
  • Product Category: Akovaz
  • Overview
  • Performance
  • Product Category: Bloxiverz
  • Overview
  • Performance
  • Product Category: Vazculep
  • Overview
  • Performance
  • Product Category: License and Research Revenue
  • Performance
  • Product Category: Other
  • Performance
  • R&D Overview
  • Avadel Pharmaceuticals Plc - Corporate Strategy
  • Avadel Pharmaceuticals Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Avadel Pharmaceuticals Plc - Strengths
  • Avadel Pharmaceuticals Plc - Weaknesses
  • Avadel Pharmaceuticals Plc - Opportunities
  • Avadel Pharmaceuticals Plc - Threats
  • Avadel Pharmaceuticals Plc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Avadel Pharmaceuticals Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 07, 2018: Avadel Pharmaceuticals reports second quarter 2018 financial results
  • May 02, 2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results
  • Mar 22, 2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer
  • Mar 08, 2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results
  • Dec 29, 2017: Avadel Pharmaceuticals Issues 2018 Corporate Outlook
  • Nov 08, 2017: Avadel Pharmaceuticals Reports Third Quarter 2017 Results
  • Aug 08, 2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results
  • May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results
  • Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce
  • Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Avadel Pharmaceuticals Plc, Key Facts
  • Avadel Pharmaceuticals Plc, Key Employees
  • Avadel Pharmaceuticals Plc, Key Employee Biographies
  • Avadel Pharmaceuticals Plc, Major Products and Services
  • Avadel Pharmaceuticals Plc, History
  • Avadel Pharmaceuticals Plc, Subsidiaries
  • Avadel Pharmaceuticals Plc, Key Competitors
  • Avadel Pharmaceuticals Plc, Ratios based on current share price
  • Avadel Pharmaceuticals Plc, Annual Ratios
  • Avadel Pharmaceuticals Plc, Annual Ratios
  • Avadel Pharmaceuticals Plc, Annual Ratios
  • Avadel Pharmaceuticals Plc, Interim Ratios
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Avadel Pharmaceuticals Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Avadel Pharmaceuticals Plc, Performance Chart (2013 - 2017)
  • Avadel Pharmaceuticals Plc, Ratio Charts
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Veloxis Pharmaceuticals Inc
  • Elite Pharmaceuticals Inc
  • DURECT Corp
  • Depomed Inc
  • Albireo Pharma Inc
  • Acura Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll